Bloomberg Law And Epstein Becker Green Update Telehealth Portfolio

ARLINGTON, Va. and WASHINGTON, July 19, 2017 /PRNewswire-USNewswire/ -- Bloomberg Law and Epstein Becker Green (EBG) announced today the publication of a new edition of Navigating the Telehealth Landscape: Legal and Regulatory Issues, a portfolio that focuses on the growing use of telehealth technologies and services and analyzes the federal and state issues impacting the utilization of telehealth services. The Portfolio, which is available to Bloomberg Law subscribers, is written by EBG's Amy F. Lerman and Charles C. Dunham, IV. To download an excerpt of Navigating the Telehealth Landscape: Legal and Regulatory Issues, visit http://on.bna.com/oUvo30dL96l.

  1. Portfolio discusses how the growing use of telehealth technologies and services presents a number of significant legal and regulatory issues, many of which present challenges for providers and users of this nascent technology. While these issues have arisen at both the federal and state levels, compliance with state laws takes on greater importance given the professional licensure and scope of practice issues involved with telehealth.

"A combination of technological advances, efforts to contain runaway health care costs, and the need to make health care more accessible is fueling the continuing rapid growth of telehealth services," said Scott Falk, Vice President and General Manager, Health Care & Litigation, Bloomberg Law. "However, with these services, novel legal issues arise due to interactions among patients and providers through communications channels including email, telephone and video conferencing. We are grateful for Amy's and Charles's contributions in developing this comprehensive resource for health care professionals (and attorneys) that addresses the many diverse legal challenges unique to telemedicine."

"According to a 2016 study, an estimated 61 percent of health care institutions currently use some form of telehealth technology, and between 40 and 50 percent of all hospitals in the U.S. now utilize some form of telehealth technology in their provision of health care services. So telemedicine is certainly here to stay," said Ms. Lerman. "And that's why it is important that health care providers, physicians, employers, and other users are up to speed on the various complex issues that this exciting technology presents."

"There have been movements at the state and federal level with regard to telehealth advancement. So the future, while somewhat unknown, is promising," said Mr. Dunham. "We were pleased to partner with Bloomberg BNA on this project, and we hope that those who read it find the Portfolio insightful and thought provoking."

Bloomberg Law portfolios are written by expert practitioners and feature deep-dive analysis and practice tools, such as checklists, sample client letters, forms and other supporting material, on a wide range of key legal topics. For information on the full range of health care resources available on Bloomberg Law visit http://on.bna.com/Lyht30dL91W.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.